Form 4 for EVH Evolent Health, Inc.
Accepted 2024-02-26 00:00:00 ET · period of report 2024-02-22 · accession 0001628908-24-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-26 | 2024-02-22 | EVH | Blackley Seth | CEO, Dir | A - Grant | $0.00 | +206.2K | 843.9K | +32% | $0 | |
| 2024-02-26 | 2024-02-22 | EVH | Blackley Seth | CEO, Dir | F - Tax | $33.03 | -88.6K | 755.3K | -10% | -$2.93M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-22 | A | A | 206,209 | $0.00 | 843,854 | D | — | — | (F1) Represents the number of shares received upon the settlement of the second tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the second tranche of the PSU award vested at the conclusion of the performance period on December 31, 2023. (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 2 | Common | Class A Common Stock | 2024-02-22 | F | D | 88,563 | $33.03 | 755,291 | D | — | — | (F3) This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of performance stock units. (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |